239 related articles for article (PubMed ID: 36164321)
1. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
Giri PS; Mistry J; Dwivedi M
J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
[TBL] [Abstract][Full Text] [Related]
2. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
3. Compromised melanocyte survival due to decreased suppression of CD4
Shah F; Giri PS; Bharti AH; Dwivedi M
Exp Dermatol; 2024 Jan; 33(1):e14982. PubMed ID: 37994568
[TBL] [Abstract][Full Text] [Related]
4. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
Giri PS; Bharti AH; Begum R; Dwivedi M
Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
[TBL] [Abstract][Full Text] [Related]
5. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cell cytokines in patients with nonsegmental vitiligo.
Kidir M; Karabulut AA; Ercin ME; Atasoy P
Int J Dermatol; 2017 May; 56(5):581-588. PubMed ID: 28247923
[TBL] [Abstract][Full Text] [Related]
7. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients.
Giri PS; Dwivedi M; Laddha NC; Begum R; Bharti AH
Pigment Cell Melanoma Res; 2020 Jul; 33(4):566-578. PubMed ID: 31917889
[TBL] [Abstract][Full Text] [Related]
9. Decreased
Giri PS; Bharti AH; Dwivedi M
J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
[TBL] [Abstract][Full Text] [Related]
10. Effect of narrow band-ultraviolet B on CD4(+) CD25(high) FoxP3(+) T-lymphocytes in the peripheral blood of vitiligo patients.
Moftah NH; El-Barbary RA; Ismail MA; Ali NA
Photodermatol Photoimmunol Photomed; 2014 Oct; 30(5):254-61. PubMed ID: 24372806
[TBL] [Abstract][Full Text] [Related]
11. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
Giri PS; Patel S; Begum R; Dwivedi M
Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
[TBL] [Abstract][Full Text] [Related]
13. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.
Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z
J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998
[TBL] [Abstract][Full Text] [Related]
14. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
[TBL] [Abstract][Full Text] [Related]
18. Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8
Sun J; Yang Y; Huo X; Zhu B; Li Z; Jiang X; Xie R; Gao L; Sun Y; Fan H; Zhu Y; Yang J
J Immunol Res; 2019; 2019():8575407. PubMed ID: 30915372
[TBL] [Abstract][Full Text] [Related]
19. Human CD4
Brown ME; Peters LD; Hanbali SR; Arnoletti JM; Sachs LK; Nguyen KQ; Carpenter EB; Seay HR; Fuhrman CA; Posgai AL; Shapiro MR; Brusko TM
Front Immunol; 2022; 13():873560. PubMed ID: 35693814
[TBL] [Abstract][Full Text] [Related]
20. Expression of Th17- and Treg-specific transcription factors in vitiligo patients.
Bhardwaj S; Rani S; Kumaran MS; Bhatia A; Parsad D
Int J Dermatol; 2020 Apr; 59(4):474-481. PubMed ID: 31909498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]